id	sid	eid	entity	type
ajird-8	1	1	12	CARDINAL
ajird-8	2	1	the food and drug administration	ORG
ajird-8	2	2	fda	ORG
ajird-8	2	3	kabul	GPE
ajird-8	2	4	afghanistan	GPE
ajird-8	2	5	2021	CARDINAL
ajird-8	3	1	murtaza	GPE
ajird-8	3	2	4	CARDINAL
ajird-8	3	3	mohammad basir	PERSON
ajird-8	3	4	1	CARDINAL
ajird-8	3	5	cheragh medical institute and hospital	ORG
ajird-8	3	6	kabul	GPE
ajird-8	3	7	afghanistan	GPE
ajird-8	5	1	2.	CARDINAL
ajird-8	5	2	cheragh medical institute and hospital	ORG
ajird-8	5	3	kabul	GPE
ajird-8	6	1	obstetrician	NORP
ajird-8	6	2	md.	GPE
ajird-8	7	1	3	CARDINAL
ajird-8	7	2	cheragh medical institute and hospital	ORG
ajird-8	7	3	afghanistan	GPE
ajird-8	9	1	4.	CARDINAL
ajird-8	9	2	cheragh medical institute and hospital	ORG
ajird-8	9	3	kabul	GPE
ajird-8	9	4	afghanistan	GPE
ajird-8	10	1	5	CARDINAL
ajird-8	11	1	cheragh medical institute and hospital	ORG
ajird-8	11	2	kabul	GPE
ajird-8	11	3	afghanistan	GPE
ajird-8	16	1	the food and drug administration	ORG
ajird-8	17	1	34	CARDINAL
ajird-8	17	2	kabul city	GPE
ajird-8	17	3	4 months	DATE
ajird-8	17	4	2021	DATE
ajird-8	17	5	612	CARDINAL
ajird-8	18	1	612	CARDINAL
ajird-8	18	2	about 2107	CARDINAL
ajird-8	18	3	four months	DATE
ajird-8	19	1	32.90%	PERCENT
ajird-8	19	2	28.10%	PERCENT
ajird-8	19	3	19.90%	PERCENT
ajird-8	19	4	10.80%	PERCENT
ajird-8	19	5	8.10%	PERCENT
ajird-8	20	1	60.90%	PERCENT
ajird-8	20	2	57.4%	PERCENT
ajird-8	20	3	16.5%	PERCENT
ajird-8	20	4	9.2%	PERCENT
ajird-8	20	5	0.00%	PERCENT
ajird-8	21	1	about 612	CARDINAL
ajird-8	22	1	13	CARDINAL
ajird-8	25	1	fda	ORG
ajird-8	25	2	kabul	GPE
ajird-8	25	3	afghanistan	GPE
ajird-8	26	1	1	CARDINAL
ajird-8	29	1	1960	DATE
ajird-8	29	2	di ethylstilbestrol	ORG
ajird-8	31	1	17	CARDINAL
ajird-8	35	1	gfr	ORG
ajird-8	38	1	19	CARDINAL
ajird-8	38	2	fda	ORG
ajird-8	38	3	five	CARDINAL
ajird-8	39	1	17	CARDINAL
ajird-8	39	2	first	ORDINAL
ajird-8	41	1	first	ORDINAL
ajird-8	42	1	14	CARDINAL
ajird-8	49	1	1	CARDINAL
ajird-8	49	2	16	CARDINAL
ajird-8	50	1	solomon	PERSON
ajird-8	50	2	617	CARDINAL
ajird-8	50	3	26.6%	PERCENT
ajird-8	51	1	11	CARDINAL
ajird-8	51	2	china	GPE
ajird-8	51	3	11.7%	PERCENT
ajird-8	51	4	at least one	CARDINAL
ajird-8	53	1	65.5%	PERCENT
ajird-8	53	2	first	ORDINAL
ajird-8	53	3	12.4%	PERCENT
ajird-8	54	1	49.3%	PERCENT
ajird-8	54	2	48.1%	PERCENT
ajird-8	55	1	6.2%	PERCENT
ajird-8	56	1	10	CARDINAL
ajird-8	56	2	saudi arabia	GPE
ajird-8	56	3	760	CARDINAL
ajird-8	56	4	about 500	CARDINAL
ajird-8	56	5	65.8%	PERCENT
ajird-8	56	6	340	CARDINAL
ajird-8	56	7	44.7%	PERCENT
ajird-8	56	8	between 30 and 40 years old	DATE
ajird-8	56	9	620	CARDINAL
ajird-8	56	10	81.8%	PERCENT
ajird-8	57	1	nsaids	ORG
ajird-8	57	2	1.3%	PERCENT
ajird-8	57	3	13.2%	PERCENT
ajird-8	57	4	2.6%	PERCENT
ajird-8	57	5	antihistaminic	ORG
ajird-8	57	6	1.3%	PERCENT
ajird-8	57	7	2.6%	PERCENT
ajird-8	57	8	13.2%	PERCENT
ajird-8	58	1	14	CARDINAL
ajird-8	58	2	india	GPE
ajird-8	58	3	26.10%	PERCENT
ajird-8	58	4	2%	PERCENT
ajird-8	58	5	0.57%	PERCENT
ajird-8	58	6	antiulcer	PERSON
ajird-8	58	7	23.06%	PERCENT
ajird-8	58	8	18.51%	PERCENT
ajird-8	58	9	14.92%	PERCENT
ajird-8	58	10	6.24%	PERCENT
ajird-8	58	11	16.58%	PERCENT
ajird-8	58	12	56.73%	PERCENT
ajird-8	58	13	16.64%	PERCENT
ajird-8	58	14	8.78%	PERCENT
ajird-8	58	15	1.24%	PERCENT
ajird-8	59	1	between 21 to 25 years	DATE
ajird-8	59	2	52.04%	PERCENT
ajird-8	60	1	one	CARDINAL
ajird-8	60	2	2.91%	PERCENT
ajird-8	60	3	two	CARDINAL
ajird-8	60	4	22.33%	PERCENT
ajird-8	60	5	three	CARDINAL
ajird-8	60	6	26.94%	PERCENT
ajird-8	60	7	four	CARDINAL
ajird-8	60	8	16.01%	PERCENT
ajird-8	60	9	five	CARDINAL
ajird-8	60	10	9.46%	PERCENT
ajird-8	60	11	more than five	CARDINAL
ajird-8	60	12	22.33%	PERCENT
ajird-8	61	1	4.66	CARDINAL
ajird-8	61	2	2	CARDINAL
ajird-8	62	1	15	CARDINAL
ajird-8	63	1	38%	PERCENT
ajird-8	63	2	the world health organization	ORG
ajird-8	63	3	100%	PERCENT
ajird-8	64	1	4	CARDINAL
ajird-8	64	2	turkey	GPE
ajird-8	64	3	17.6%	PERCENT
ajird-8	64	4	10.7%	PERCENT
ajird-8	64	5	9%	PERCENT
ajird-8	65	1	13	CARDINAL
ajird-8	65	2	200	CARDINAL
ajird-8	65	3	hamadan	GPE
ajird-8	65	4	iran	GPE
ajird-8	66	1	three	CARDINAL
ajird-8	66	2	48.8%	PERCENT
ajird-8	66	3	65.6%	PERCENT
ajird-8	66	4	66.7%	PERCENT
ajird-8	68	1	first	ORDINAL
ajird-8	68	2	44.2%	PERCENT
ajird-8	68	3	second	ORDINAL
ajird-8	68	4	53.1%	PERCENT
ajird-8	68	5	third	ORDINAL
ajird-8	68	6	42.4%	PERCENT
ajird-8	68	7	42.5%	PERCENT
ajird-8	69	1	44%	PERCENT
ajird-8	69	2	iran	GPE
ajird-8	69	3	at least one	CARDINAL
ajird-8	71	1	2	CARDINAL
ajird-8	71	2	canada	GPE
ajird-8	71	3	18575	DATE
ajird-8	71	4	25 to 29 years	DATE
ajird-8	71	5	39.20%	PERCENT
ajird-8	71	6	first	ORDINAL
ajird-8	72	1	15.8%	PERCENT
ajird-8	72	2	first	ORDINAL
ajird-8	72	3	3.7%	PERCENT
ajird-8	72	4	first	ORDINAL
ajird-8	73	1	18	CARDINAL
ajird-8	73	2	pakistan	GPE
ajird-8	73	3	3769	CARDINAL
ajird-8	73	4	79.4%	PERCENT
ajird-8	73	5	6.2%	PERCENT
ajird-8	73	6	1.2%	PERCENT
ajird-8	73	7	0.6%	PERCENT
ajird-8	73	8	1.5%	PERCENT
ajird-8	74	1	6	CARDINAL
ajird-8	74	2	italy	GPE
ajird-8	74	3	70%	PERCENT
ajird-8	75	1	9	CARDINAL
ajird-8	75	2	hungary	GPE
ajird-8	75	3	70%	PERCENT
ajird-8	76	1	5	CARDINAL
ajird-8	76	2	64%	PERCENT
ajird-8	77	1	12	CARDINAL
ajird-8	77	2	denmark	GPE
ajird-8	77	3	42%	PERCENT
ajird-8	78	1	15	CARDINAL
ajird-8	78	2	france	GPE
ajird-8	78	3	93%	PERCENT
ajird-8	79	1	3	CARDINAL
ajird-8	79	2	norway	GPE
ajird-8	79	3	57%	PERCENT
ajird-8	80	1	8	CARDINAL
ajird-8	81	1	the united states	GPE
ajird-8	81	2	4.8%	PERCENT
ajird-8	81	3	france	GPE
ajird-8	81	4	95%	PERCENT
ajird-8	81	5	italy	GPE
ajird-8	81	6	2%	PERCENT
ajird-8	81	7	canada	GPE
ajird-8	81	8	7.3%	PERCENT
ajird-8	82	1	the united states	GPE
ajird-8	82	2	4.6%	PERCENT
ajird-8	82	3	france	GPE
ajird-8	82	4	1.6%	PERCENT
ajird-8	82	5	italy	GPE
ajird-8	82	6	1%	PERCENT
ajird-8	83	1	italy	GPE
ajird-8	84	1	the united states	GPE
ajird-8	84	2	china	GPE
ajird-8	84	3	france	GPE
ajird-8	86	1	2	CARDINAL
ajird-8	86	2	kabul	GPE
ajird-8	86	3	the 4 months of 2021	DATE
ajird-8	86	4	the food and drug administration	ORG
ajird-8	86	5	fda	ORG
ajird-8	88	1	2.1	CARDINAL
ajird-8	89	1	34	CARDINAL
ajird-8	89	2	kabul city	GPE
ajird-8	89	3	4 months	DATE
ajird-8	89	4	april 15 to august 15	DATE
ajird-8	90	1	4 16	QUANTITY
ajird-8	92	1	2.2	CARDINAL
ajird-8	92	2	612	CARDINAL
ajird-8	92	3	ibm	ORG
ajird-8	93	1	26	CARDINAL
ajird-8	94	1	ibm	ORG
ajird-8	95	1	26	CARDINAL
ajird-8	96	1	2.3	CARDINAL
ajird-8	97	1	3	CARDINAL
ajird-8	97	2	3.1	CARDINAL
ajird-8	97	3	612	CARDINAL
ajird-8	97	4	194	CARDINAL
ajird-8	97	5	20 to 30 years	DATE
ajird-8	97	6	247	CARDINAL
ajird-8	97	7	between 31 to 40 years old	DATE
ajird-8	97	8	171	CARDINAL
ajird-8	97	9	between 41 to 50 years old	CARDINAL
ajird-8	98	1	between 31 and 40 years old	DATE
ajird-8	99	1	1	CARDINAL
ajird-8	99	2	1	CARDINAL
ajird-8	99	3	20	CARDINAL
ajird-8	99	4	72.1	CARDINAL
ajird-8	99	5	27.9 27.9 100.0	CARDINAL
ajird-8	99	6	612	CARDINAL
ajird-8	99	7	612	CARDINAL
ajird-8	99	8	117	CARDINAL
ajird-8	99	9	161	CARDINAL
ajird-8	99	10	140	CARDINAL
ajird-8	99	11	120	CARDINAL
ajird-8	99	12	74	CARDINAL
ajird-8	101	1	2	CARDINAL
ajird-8	101	2	2	CARDINAL
ajird-8	101	3	117	CARDINAL
ajird-8	101	4	19.1	CARDINAL
ajird-8	101	5	19.1	CARDINAL
ajird-8	101	6	161	CARDINAL
ajird-8	101	7	26.3 26.3 45.4	QUANTITY
ajird-8	101	8	140	CARDINAL
ajird-8	101	9	22.9 22.9	CARDINAL
ajird-8	101	10	68.3	CARDINAL
ajird-8	101	11	120	CARDINAL
ajird-8	101	12	19.6	CARDINAL
ajird-8	101	13	87.9	CARDINAL
ajird-8	101	14	74	CARDINAL
ajird-8	101	15	12.1 12.1 100.0	CARDINAL
ajird-8	101	16	612	CARDINAL
ajird-8	101	17	612	CARDINAL
ajird-8	101	18	333	CARDINAL
ajird-8	101	19	42	CARDINAL
ajird-8	101	20	88	CARDINAL
ajird-8	101	21	149	CARDINAL
ajird-8	102	1	17	CARDINAL
ajird-8	104	1	3	CARDINAL
ajird-8	105	1	3	CARDINAL
ajird-8	105	2	333 54.4	CARDINAL
ajird-8	105	3	42	CARDINAL
ajird-8	105	4	61.3	CARDINAL
ajird-8	105	5	88	CARDINAL
ajird-8	105	6	14.4 14.4 75.7	QUANTITY
ajird-8	105	7	149	CARDINAL
ajird-8	105	8	24.3 24.3 100.0	QUANTITY
ajird-8	105	9	612	CARDINAL
ajird-8	105	10	3.2.1	CARDINAL
ajird-8	105	11	612	CARDINAL
ajird-8	105	12	223	CARDINAL
ajird-8	105	13	first	ORDINAL
ajird-8	105	14	197	CARDINAL
ajird-8	105	15	second	ORDINAL
ajird-8	105	16	192	CARDINAL
ajird-8	105	17	third	ORDINAL
ajird-8	106	1	first	ORDINAL
ajird-8	107	1	4	CARDINAL
ajird-8	107	2	4	CARDINAL
ajird-8	107	3	first	ORDINAL
ajird-8	107	4	223	CARDINAL
ajird-8	107	5	36.4 second	TIME
ajird-8	107	6	197	CARDINAL
ajird-8	107	7	68.6 third	CARDINAL
ajird-8	107	8	192	CARDINAL
ajird-8	107	9	100.0	CARDINAL
ajird-8	107	10	612	CARDINAL
ajird-8	107	11	3.2.2	CARDINAL
ajird-8	107	12	612	CARDINAL
ajird-8	107	13	128	CARDINAL
ajird-8	107	14	first	ORDINAL
ajird-8	107	15	409	CARDINAL
ajird-8	107	16	1 3	CARDINAL
ajird-8	107	17	75	CARDINAL
ajird-8	107	18	more than 3	CARDINAL
ajird-8	108	1	5	CARDINAL
ajird-8	108	2	5	CARDINAL
ajird-8	108	3	first	ORDINAL
ajird-8	108	4	128	CARDINAL
ajird-8	108	5	20.9	CARDINAL
ajird-8	108	6	20.9	CARDINAL
ajird-8	108	7	1 3	CARDINAL
ajird-8	108	8	409	CARDINAL
ajird-8	108	9	66.8 87.7	CARDINAL
ajird-8	108	10	more than 3	CARDINAL
ajird-8	108	11	75	CARDINAL
ajird-8	108	12	12.3 100.0	CARDINAL
ajird-8	108	13	612	CARDINAL
ajird-8	108	14	612	CARDINAL
ajird-8	108	15	35	CARDINAL
ajird-8	108	16	577	CARDINAL
ajird-8	109	1	6	CARDINAL
ajird-8	109	2	6	CARDINAL
ajird-8	110	1	35	CARDINAL
ajird-8	110	2	100.0	CARDINAL
ajird-8	110	3	612	CARDINAL
ajird-8	111	1	3.3	CARDINAL
ajird-8	111	2	3.3.1	CARDINAL
ajird-8	111	3	612	CARDINAL
ajird-8	111	4	454	CARDINAL
ajird-8	111	5	158	CARDINAL
ajird-8	111	6	kabul	GPE
ajird-8	112	1	7	CARDINAL
ajird-8	112	2	7	CARDINAL
ajird-8	112	3	454	CARDINAL
ajird-8	112	4	74.2	CARDINAL
ajird-8	112	5	74.2	CARDINAL
ajird-8	112	6	158	CARDINAL
ajird-8	112	7	25.8 25.8 100.0	QUANTITY
ajird-8	112	8	612	CARDINAL
ajird-8	112	9	100.0 3.3.2	CARDINAL
ajird-8	112	10	612	CARDINAL
ajird-8	114	1	128	CARDINAL
ajird-8	115	1	82	CARDINAL
ajird-8	115	2	one	CARDINAL
ajird-8	115	3	158	CARDINAL
ajird-8	115	4	2	CARDINAL
ajird-8	115	5	106	CARDINAL
ajird-8	115	6	only 3	CARDINAL
ajird-8	115	7	67	CARDINAL
ajird-8	115	8	4	CARDINAL
ajird-8	115	9	35	CARDINAL
ajird-8	115	10	36	CARDINAL
ajird-8	115	11	five	CARDINAL
ajird-8	115	12	more than five	CARDINAL
ajird-8	116	1	8)	CARDINAL
ajird-8	116	2	8)	CARDINAL
ajird-8	116	3	zero	CARDINAL
ajird-8	116	4	20.9	CARDINAL
ajird-8	116	5	20.9	CARDINAL
ajird-8	116	6	20.9	CARDINAL
ajird-8	116	7	13.4	CARDINAL
ajird-8	116	8	13.4	CARDINAL
ajird-8	116	9	34.3	CARDINAL
ajird-8	116	10	158	CARDINAL
ajird-8	116	11	25.8 25.8 60.1	QUANTITY
ajird-8	116	12	106	CARDINAL
ajird-8	116	13	17.3 17.3 77.5	QUANTITY
ajird-8	116	14	four	CARDINAL
ajird-8	116	15	10.9	CARDINAL
ajird-8	116	16	5.7 94.1	CARDINAL
ajird-8	116	17	5.9 100.0	CARDINAL
ajird-8	116	18	612	CARDINAL
ajird-8	116	19	60.90%	PERCENT
ajird-8	116	20	57.40%	PERCENT
ajird-8	116	21	16.50%	PERCENT
ajird-8	116	22	9.20%	PERCENT
ajird-8	116	23	0.00%	PERCENT
ajird-8	116	24	x.	ORG
ajird-8	117	1	x.	ORG
ajird-8	117	2	1	CARDINAL
ajird-8	117	3	fda	ORG
ajird-8	117	4	19 |	CARDINAL
ajird-8	118	1	32.90%	PERCENT
ajird-8	118	2	8.10%	PERCENT
ajird-8	118	3	10.80%	PERCENT
ajird-8	118	4	19.90%	PERCENT
ajird-8	118	5	28.10%	PERCENT
ajird-8	118	6	0.20 %	PERCENT
ajird-8	118	7	kabul	GPE
ajird-8	118	8	afghanistan	GPE
ajird-8	119	1	series1	PERSON
ajird-8	119	2	60.90%	PERCENT
ajird-8	119	3	57.40%	PERCENT
ajird-8	119	4	16.50%	PERCENT
ajird-8	119	5	9.20%	PERCENT
ajird-8	119	6	0.00%	PERCENT
ajird-8	119	7	0.00%	PERCENT
ajird-8	119	8	10.00%	PERCENT
ajird-8	119	9	20.00%	PERCENT
ajird-8	119	10	30.00%	PERCENT
ajird-8	119	11	40.00%	PERCENT
ajird-8	119	12	50.00%	PERCENT
ajird-8	119	13	60.00%	PERCENT
ajird-8	119	14	70.00%	PERCENT
ajird-8	119	15	1	CARDINAL
ajird-8	119	16	fda	ORG
ajird-8	119	17	series1 32.90%	LAW
ajird-8	119	18	8.10%	PERCENT
ajird-8	119	19	10.80%	PERCENT
ajird-8	119	20	19.90%	PERCENT
ajird-8	119	21	28.10%	PERCENT
ajird-8	119	22	0.20%	PERCENT
ajird-8	119	23	0.00%	PERCENT
ajird-8	119	24	5.00%	PERCENT
ajird-8	119	25	10.00%	PERCENT
ajird-8	119	26	15.00%	PERCENT
ajird-8	119	27	20.00%	PERCENT
ajird-8	119	28	25.00%	PERCENT
ajird-8	119	29	30.00%	PERCENT
ajird-8	119	30	35.00%	PERCENT
ajird-8	119	31	american journal of interdisciplinary research	ORG
ajird-8	119	32	2771-8948	CARDINAL
ajird-8	119	33	01	CARDINAL
ajird-8	119	34	february	DATE
ajird-8	119	35	2022	CARDINAL
ajird-8	120	1	about (	CARDINAL
ajird-8	120	2	612	CARDINAL
ajird-8	120	3	four months	DATE
ajird-8	120	4	kabul	GPE
ajird-8	121	1	3.44	CARDINAL
ajird-8	121	2	india	GPE
ajird-8	121	3	4.66	CARDINAL
ajird-8	121	4	the world health organization	ORG
ajird-8	121	5	2.00	CARDINAL
ajird-8	122	1	31 to 40 years	DATE
ajird-8	122	2	saudi arabia	GPE
ajird-8	122	3	30 to 40 years	DATE
ajird-8	122	4	44.7%	PERCENT
ajird-8	123	1	india	GPE
ajird-8	123	2	between 21 and 25 years old	DATE
ajird-8	123	3	52.04%	PERCENT
ajird-8	124	1	saudi arabia	GPE
ajird-8	124	2	65.8%	PERCENT
ajird-8	125	1	afghanistan	GPE
ajird-8	127	1	saudi	GPE
ajird-8	127	2	81.8%	PERCENT
ajird-8	128	1	canada	GPE
ajird-8	128	2	39.20%	PERCENT
ajird-8	129	1	afghanistan	GPE
ajird-8	130	1	5.7%	PERCENT
ajird-8	130	2	saudi arabia	GPE
ajird-8	130	3	6.6%	PERCENT
ajird-8	133	1	128	CARDINAL
ajird-8	134	1	india	GPE
ajird-8	134	2	38%	PERCENT
ajird-8	134	3	the world health organization	ORG
ajird-8	134	4	100%	PERCENT
ajird-8	135	1	kabul	GPE
ajird-8	135	2	afghanistan	GPE
ajird-8	136	1	iran	GPE
ajird-8	136	2	india	GPE
ajird-8	137	1	kabul	GPE
ajird-8	137	2	9.20%	PERCENT
ajird-8	137	3	france	GPE
ajird-8	137	4	95%	PERCENT
ajird-8	137	5	india	GPE
ajird-8	137	6	the united states	GPE
ajird-8	137	7	italy	GPE
ajird-8	137	8	canada	GPE
ajird-8	138	1	kabul	GPE
ajird-8	138	2	afghanistan	GPE
ajird-8	140	1	india	GPE
ajird-8	140	2	iran	GPE
ajird-8	141	1	india	GPE
ajird-8	141	2	saudi arabia	GPE
ajird-8	141	3	standard american journal of interdisciplinary research and	ORG
ajird-8	141	4	2771-8948	CARDINAL
ajird-8	141	5	01	CARDINAL
ajird-8	141	6	february	DATE
ajird-8	141	7	2022 21	DATE
ajird-8	142	1	30%	PERCENT
ajird-8	143	1	second	ORDINAL
ajird-8	143	2	pakistan	GPE
ajird-8	143	3	79.4%	PERCENT
ajird-8	143	4	arab	NORP
ajird-8	143	5	indian	NORP
ajird-8	143	6	13.2	CARDINAL
ajird-8	145	1	14.92%	PERCENT
ajird-8	146	1	5	CARDINAL
ajird-8	152	1		CARDINAL
ajird-8	152	2		CARDINAL
ajird-8	153	1		CARDINAL
ajird-8	153	2		CARDINAL
ajird-8	155	1	cheragh institute	ORG
ajird-8	156	1	cheragh medical institute	ORG
ajird-8	156	2	kabul	GPE
ajird-8	156	3	afghanistan	GPE
ajird-8	159	1	1	CARDINAL
ajird-8	159	2	aftab, k. (	PERSON
ajird-8	159	3	2018	DATE
ajird-8	161	1	sialkot medical college	ORG
ajird-8	161	2	sialkot	GPE
ajird-8	161	3	pakistan	GPE
ajird-8	162	1	1	CARDINAL
ajird-8	162	2	2	CARDINAL
ajird-8	162	3	araghchian	NORP
ajird-8	162	4	m. radnia	PERSON
ajird-8	162	5	m. (	PERSON
ajird-8	162	6	2011	DATE
ajird-8	163	1	fda	ORG
ajird-8	163	2	hamadan	GPE
ajird-8	164	1	hamadan university of medical sciences	ORG
ajird-8	165	1	41	CARDINAL
ajird-8	165	2	edical_and_health_centers_in_hamadan	PERSON
ajird-8	165	3	https://www.researchgate.net/publication/270704217_the_pattern_of_drug_use_and_their_fda_categories_in_pregnant_women_referring_to_medical_and_health_centers_in_hamadan	ORG
ajird-8	165	4	https://www.researchgate.net/publication/270704217_the_pattern_of_drug_use_and_their_fda_categories_in_pregnant_women_referring_to_medical_and_health_centers_in_hamadan american	NORP
ajird-8	165	5	2771-8948	CARDINAL
ajird-8	165	6	01	CARDINAL
ajird-8	165	7	february	DATE
ajird-8	165	8	2022	CARDINAL
ajird-8	166	1	andrade se	PERSON
ajird-8	166	2	gurwitz jh	PERSON
ajird-8	166	3	davis rl	PERSON
ajird-8	166	4	chan ka	PERSON
ajird-8	166	5	finkelstein ja	PERSON
ajird-8	168	1	2004	DATE
ajird-8	170	1	191	CARDINAL
ajird-8	170	2	398	CARDINAL
ajird-8	171	1	4	CARDINAL
ajird-8	171	2	binu	PERSON
ajird-8	171	3	pavani	NORP
ajird-8	171	4	al. sujatha	PERSON
ajird-8	171	5	d. pavani	PERSON
ajird-8	172	1	2016	CARDINAL
ajird-8	174	1	world journal of pharmaceutical research	ORG
ajird-8	174	2	5	CARDINAL
ajird-8	174	3	9	CARDINAL
ajird-8	175	1	karnataka	GPE
ajird-8	175	2	india	GPE
ajird-8	176	1	891901	DATE
ajird-8	177	1	5	CARDINAL
ajird-8	177	2	czeizel ae	PERSON
ajird-8	178	1	2004	DATE
ajird-8	180	1	13	CARDINAL
ajird-8	180	2	740-745	CARDINAL
ajird-8	182	1	kr	PERSON
ajird-8	182	2	nirmal	PERSON
ajird-8	182	3	d. syed	PERSON
ajird-8	182	4	ia	GPE
ajird-8	182	5	nazir	PERSON
ajird-8	183	1	zahida	ORG
ajird-8	183	2	m. abdul	PERSON
ajird-8	183	3	nusrat	PERSON
ajird-8	183	4	hk	GPE
ajird-8	183	5	2008	DATE
ajird-8	184	1	pakistan	GPE
ajird-8	187	1	doug	PERSON
ajird-8	187	2	elizabeth	PERSON
ajird-8	187	3	melissa	PERSON
ajird-8	187	4	c. elizabeth	PERSON
ajird-8	187	5	f., lindsey	PERSON
ajird-8	187	6	j. chad	PERSON
ajird-8	187	7	h. meghan	PERSON
ajird-8	187	8	m. shelley o	PERSON
ajird-8	187	9	jason s.	PERSON
ajird-8	187	10	2013	DATE
ajird-8	188	1	8	CARDINAL
ajird-8	188	2	daltveit ak	GPE
ajird-8	188	3	skurtveit sv	PERSON
ajird-8	188	4	2004–2006	CARDINAL
ajird-8	190	1	106 000	CARDINAL
ajird-8	190	2	norway	GPE
ajird-8	192	1	j clin pharmacol 2008;65	PERSON
ajird-8	192	2	653–660	CARDINAL
ajird-8	193	1	9	CARDINAL
ajird-8	193	2	gagne jj	PERSON
ajird-8	193	3	maio	DATE
ajird-8	193	4	louis dz	PERSON
ajird-8	193	5	gon-nella	ORG
ajird-8	193	6	2008	DATE
ajird-8	194	1	emilia romagna	PERSON
ajird-8	194	2	italy	GPE
ajird-8	195	1	ejur	GPE
ajird-8	195	2	j clin pharmacol	PERSON
ajird-8	195	3	64:1125–1132	CARDINAL
ajird-8	197	1	jingyuan, z. carolina	PERSON
ajird-8	197	2	olu	GPE
ajird-8	197	3	anita	PERSON
ajird-8	197	4	xiaodong	PERSON
ajird-8	197	5	s.	PERSON
ajird-8	197	6	2019	DATE
ajird-8	198	1	china	GPE
ajird-8	200	1	peking university	ORG
ajird-8	200	2	beijing	GPE
ajird-8	200	3	china	GPE
ajird-8	201	1	1057	DATE
ajird-8	201	2	1064	CARDINAL
ajird-8	202	1	11	CARDINAL
ajird-8	203	1	g	PERSON
ajird-8	203	2	solomon	PERSON
ajird-8	203	3	w.	PERSON
ajird-8	203	4	2018	DATE
ajird-8	204	1	addis ababa	GPE
ajird-8	204	2	ethiopia	GPE
ajird-8	205	1	12	CARDINAL
ajird-8	206	1	lacroix	PERSON
ajird-8	208	1	2009	DATE
ajird-8	209	1	french	NORP
ajird-8	210	1	j clin pharmacol	PERSON
ajird-8	210	2	65	CARDINAL
ajird-8	210	3	839–846	CARDINAL
ajird-8	211	1	13	CARDINAL
ajird-8	211	2	k. cunay	PERSON
ajird-8	211	3	murat	ORG
ajird-8	211	4	k. mesut	PERSON
ajird-8	211	5	2006	DATE
ajird-8	212	1	trabzon	GPE
ajird-8	212	2	turkey	GPE
ajird-8	213	1	https://pubmed.ncbi.nlm.nih.gov/15343213/ https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/1472636448.pdf https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/1472636448.pdf https://journals.sagepub.com/doi/abs/10.1191/0961203303lu1095oa https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-8-24	ORG
ajird-8	213	2	https://pubmed.ncbi.nlm.nih.gov/18685836/ https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6911329/ https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6911329/ https://doi.org/10.1186/s41182-018-0091-z	QUANTITY
ajird-8	213	3	american journal of interdisciplinary research	ORG
ajird-8	213	4	2771-8948	CARDINAL
ajird-8	213	5	01	CARDINAL
ajird-8	213	6	february	DATE
ajird-8	213	7	2022 23	DATE
ajird-8	214	1	turkey	GPE
ajird-8	215	1	176	CARDINAL
ajird-8	215	2	177	CARDINAL
ajird-8	216	1	14	DATE
ajird-8	217	1	noha	PERSON
ajird-8	217	2	albarraq	GPE
ajird-8	217	3	a.	PERSON
ajird-8	217	4	2014	DATE
ajird-8	218	1	saudi	NORP
ajird-8	219	1	saudi pharmaceutical journal	ORG
ajird-8	220	1	taif university	ORG
ajird-8	220	2	taif	GPE
ajird-8	220	3	saudi arabia	GPE
ajird-8	221	1	419	CARDINAL
ajird-8	221	2	428	CARDINAL
ajird-8	222	1	15	CARDINAL
ajird-8	223	1	steffensen hg	PERSON
ajird-8	223	2	nielsen	PERSON
ajird-8	223	3	berg j. olsen h	PERSON
ajird-8	223	4	surensen ht	PERSON
ajird-8	224	1	1999	DATE
ajird-8	225	1	first	ORDINAL
ajird-8	225	2	danish	NORP
ajird-8	226	1	j clin pharmacol	PERSON
ajird-8	226	2	55	CARDINAL
ajird-8	226	3	139	CARDINAL
ajird-8	227	1	16	CARDINAL
ajird-8	228	1	omkar	ORG
ajird-8	228	2	s. prabhat	PERSON
ajird-8	228	3	2015	CARDINAL
ajird-8	230	1	16	CARDINAL
ajird-8	232	1	sachdeva	GPE
ajird-8	232	2	patel	PERSON
ajird-8	233	1	2009	DATE
ajird-8	235	1	india	GPE
ajird-8	235	2	sci	ORG
ajird-8	236	1	pmid 20177448.pp	PERSON
ajird-8	236	2	113	CARDINAL
ajird-8	237	1	18	DATE
ajird-8	238	1	sw	ORG
ajird-8	238	2	yang	PERSON
ajird-8	238	3	t. krewski	PERSON
ajird-8	238	4	yang	PERSON
ajird-8	238	5	q. nimrod	PERSON
ajird-8	238	6	c. garner	PERSON
ajird-8	238	7	p. fraser	PERSON
ajird-8	238	8	w. olatunbosum	PERSON
ajird-8	238	9	mc.	PERSON
ajird-8	238	10	2008	DATE
ajird-8	239	1	fda	ORG
ajird-8	239	2	canadian	NORP
ajird-8	240	1	university of ottawa	ORG
ajird-8	240	2	canada	GPE
ajird-8	241	1	324	CARDINAL
ajird-8	241	2	329	CARDINAL
ajird-8	242	1	19	CARDINAL